Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Bivrx. Invenomic fund

Thoughts re invenomic fund? Bivrx, bivix

I've instituted a starter position. Fund mgr used to manage Boston partners long short

Haven't had much success in the past with LS funds, would have been better off 30% nobl, 70% iei in overwhelming instances and time frames

Frothy markets, artificial markets....

We'll see

Best

Baseball fan

Comments

  • Based on recent performance, at least this fund is not afraid to place its bets. BIVRX is up over +3.1% today. Most long-shorts don't ACTUALLY do much shorting. Ever. So at least BIVRX has something going for it in that sense. Its not a typical L/S, other than its Expense Ratio.

    This fund can be wild (look at the YTD chart!!!) and non-conventional, so I'd keep any allocation % low. Real low. Like, "how much you could afford to lose in Vegas and not really care" low. If the PM can keep this up, it should attract a lot of new $$$. It's nimble at only $265M in Assets.

    Fun stuff. Their recent bets have been paying off.
  • @JD_co..additionally what got my attn is that in most recent fund commentary, mgr states "we feel well positioned for what lies ahead...and...we could not be more enthusiastic at the opportunities ahead of us.."

    Hmm. C Wood / ARKK recently stated on CNBC in how "she loves the set up..."

    So. One of them is likely going to be right and the other wrong. Ying vs Yang.

    You place your bets and you takes your chances...

    I'm ridin' with Invenomic.

    We'll see how it plays out.

    Best,

    Baseball Fan
  • edited May 2021
    I bought into BIVRX in early-mid 2020. Fund has done really well! Fund is up 57% according to this link (long-short equity) category.

    https://www.morningstar.com/funds/screener-rank

    Initial investment is $5K for investor class, but must maintain minimum balance of $1K afterwards in a taxable account (prospectus link below).

    https://www.sec.gov/Archives/edgar/data/1518042/000158064221000788/invenomic485b.htm.

    Check out the prior assessments by David:

    https://www.mutualfundobserver.com/2019/05/balter-invenomic-bivrx-bivix-bivsx/

    which changed to Invenomic:

    https://www.mutualfundobserver.com/2019/10/invenomic-fund-bivrx-bivix-bivsx/

    From one of the assessments:

    The manager is Ali Motamed. Before launching Invenomic Capital, Mr. Motamed was a Senior Analyst and a Portfolio Manager with Robeco Investment Management (2003-15) where he co-managed Boston Partners Long/Short Equity Fund (BPLEX) and a related strategy. He was awarded Portfolio Manager of the Year in the Alternatives Category by Morningstar in 2014.

    Found this link from Ted back in September 2019:

    https://www.fa-mag.com/news/mining-the-short-side-51224.html?print
  • Up up & away for month of May, 15.72% !!
    Derf
  • Not to get to far off-topic from the original post, but even EVDIX or EVDAX (Camelot Event Driven Fund - event driven) is having one of its best years since the fund commenced operations.
Sign In or Register to comment.